other · Healthcare · Biotechnology
MNKD
3.98-0.05 -1.24%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- MNKD
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $1.25B
- Employees
- 591
- Currency
- USD
- Website
- https://mannkindcorp.com
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow MannKind Corporation (MNKD) across major market-data sources.